Patent directory Β· USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11746102
Polymorphs of selinexor
granted -
US 11745026
Laser assisted wound healing protocol and system
granted -
US 11744812
Methods of treatment
granted -
US 11744898
Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods
granted -
US 11744893
Constrained conditionally activated binding proteins
granted -
US 11745179
Microfluidic systems and methods for lipoplex-mediated cell transfection
granted -
US 11746126
Bicyclic peptide ligands with detectable moieties and uses thereof
granted -
US 11744892
Constrained conditionally activated binding proteins
granted -
US 11746124
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
granted -
US 11746155
Cannabinoid receptor type 1 (CB1) binding proteins and uses thereof
granted -
US 11749394
Method and apparatus for providing a pharmacokinetic drug dosing regimen
granted -
US 11746335
Development of dengue virus vaccine components
granted -
US 11746120
Stat degraders and uses thereof
granted -
US 11746109
Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate
granted -
US 11744828
Regimens of tafenoquine for prevention of malaria in malaria-naΓ―ve subjects
granted -
US 11746151
Compositions and methods for treating cancer
granted -
US 11744837
Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
granted -
US 11744876
Immunomodulator antibody drug conjugates and uses thereof
granted -
US 11744873
Compositions and methods for the treatment of metabolic and liver disorders
granted -
US 11746152
Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1
granted -
US 11744926
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
granted -
US 11744790
Compositions and methods for blocking ultraviolet radiation
granted -
US 11746087
C4-carboxylic acid-substituted tryptamine derivatives and methods of using
granted -
US 11744800
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β best for looking up a specific filing or applicant portfolio slice.